Neurometrix Inc Share Price Nasdaq
Equities
US6412555004
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
||
- USD | - |
15/05 | NeuroMetrix, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
19/04 | Sector Update: Health Care Stocks Advance Late Afternoon | MT |
Sales 2022 | 82.56L 69Cr | Sales 2023 | 59.01L 49Cr | Capitalization | 38.66L 32Cr |
---|---|---|---|---|---|
Net income 2022 | -40L -33Cr | Net income 2023 | -60L -50Cr | EV / Sales 2022 | -1.12 x |
Net cash position 2022 | 2.08Cr 174.1Cr | Net cash position 2023 | 1.78Cr 148.31Cr | EV / Sales 2023 | -2.35 x |
P/E ratio 2022 |
-2.41
x | P/E ratio 2023 |
-0.57
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 0% |
Latest transcript on Neurometrix Inc
Managers | Title | Age | Since |
---|---|---|---|
Shai Gozani
CEO | Chief Executive Officer | 59 | 01/96/01 |
Thomas Higgins
DFI | Director of Finance/CFO | 72 | 10/09/10 |
Brandi Damkier
PRN | Corporate Officer/Principal | - | 10/22/10 |
Members of the board | Title | Age | Since |
---|---|---|---|
Nancy Katz
BRD | Director/Board Member | 65 | 17/10/17 |
David Goodman
BRD | Director/Board Member | 67 | 01/04/01 |
Shai Gozani
CEO | Chief Executive Officer | 59 | 01/96/01 |
1st Jan change | Capi. | |
---|---|---|
-6.68% | 18TCr | |
-5.20% | 9.88TCr | |
-5.38% | 6.53TCr | |
+15.46% | 4.54TCr | |
-6.47% | 4.49TCr | |
+9.74% | 4.38TCr | |
+14.01% | 2.9TCr | |
+19.39% | 2.56TCr | |
-6.53% | 2.33TCr |